发明名称 NAPHTHYLVERBINDUNGEN, ZWISCHENPRODUKTE, ZUSAMMENSETZUNGEN UND METHODEN
摘要 <p>The present invention provides pharmaceutically active compounds formula I <CHEM> wherein R<1> is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C2-C6 alkyl); R<2> is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), -OSO2(C2-C6 alkyl), or halo; R<3> is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidino, 4-morpholino, dimethylamino, diethylamino, diisopropylamino, or 1-hexamethyleneimino; and n is 2 or 3; and or a pharmaceutically acceptable salt thereof. Also provided are compounds of formula II <CHEM> wherein R<1a> is -H or -OR<5> in which R<5> is a hydroxy protecting group. R<2a> is -H, halo, or -OR<6> in which R<6> is a hydroxy protecting group; and R<4> is -OH or -CHO; or a pharmaceutically acceptable salt thereof. Further provided are pharmaceutical compositions of compounds of formula I, and methods of using formula I compounds for, inter alia, alleviating the symptoms of post menopausal syndrome and hormonally-dependent cancer, particularly, breast cancer.</p>
申请公布号 AT180776(T) 申请公布日期 1999.06.15
申请号 AT19960300877T 申请日期 1996.02.09
申请人 ELI LILLY AND COMPANY 发明人 PALKOWITZ, ALAN DAVID
分类号 C07D295/08;A61K31/085;A61K31/135;A61K31/235;A61K31/24;A61K31/255;A61K31/40;A61K31/4353;A61K31/445;A61K31/535;A61K31/5375;A61K31/565;A61K31/57;A61P5/30;A61P9/00;A61P9/10;A61P13/02;A61P15/00;A61P15/12;A61P19/10;A61P35/00;A61P43/00;C07C43/23;C07C43/295;C07C45/71;C07C47/575;C07C251/04;C07C309/76;C07D207/06;C07D207/12;C07D295/088;C07D295/092;(IPC1-7):C07D295/08 主分类号 C07D295/08
代理机构 代理人
主权项
地址